- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2014
- Public Summary Document (PSD) March 2014 PBAC Meeting - PDF
Aflibercept – March 2014
Aflibercept, 2 mg/0.05 mL injection, 1 x 0.05 mL vial and 2 mg/0.05 mL injection, 1 x 0.05 mL syringe, Eylea®
Last updated
8 November 2023
